Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Biochimica et Biophysica Acta - Bioenergetics

• Publication date

  2017-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bbabio.2017.02.005PMID 28213330
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Manipulation of tumor oxygenation and radiosensitivity through modification of cell respiration. A critical review of approaches and imaging biomarkers for therapeutic guidance.

  2017cited by this paper
• Multimodality Imaging Identifies Distinct Metabolic Profiles In Vitro and In Vivo1

  2016cited by this paper
• High glucose repatterns human podocyte energy metabolism during differentiation and diabetic nephropathy

  2016cited by this paper
• Metabolic Heterogeneity in Human Lung Tumors.

  2016cited by this paper
• Meta‐analysis of clinical metabolic profiling studies in cancer: challenges and opportunities

  2016cited by this paper
• Differentially Expressed miRNAs in Tumor, Adjacent, and Normal Tissues of Lung Adenocarcinoma

  2016cited by this paper
• Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer.

  2016cited by this paper
• Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival

  2016cited by this paper
• Leukemic Stem Cells Evade Chemotherapy by Metabolic Adaptation to an Adipose Tissue Niche.

  2016cited by this paper
• Systems proteomics of liver mitochondria function

  2016cited by this paper
• Enhanced OXPHOS, glutaminolysis and β-oxidation constitute the metastatic phenotype of melanoma cells.

  2016cited by this paper
• Targeting Adenine Nucleotide Translocase-2 (ANT2) to Overcome Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Non–Small Cell Lung Cancer

  2016cited by this paper
• mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells.

  2016cited by this paper
• The genetics of drug efficacy: opportunities and challenges

  2016cited by this paper
• The Emerging Hallmarks of Cancer Metabolism.

  2016cited by this paper
• Effects of Sex, Strain, and Energy Intake on Hallmarks of Aging in Mice.

  2016cited by this paper
• Fluid Dynamic Modeling to Support the Development of Flow-Based Hepatocyte Culture Systems for Metabolism Studies

  2016cited by this paper
• Hallmarks of cancer stem cell metabolism

  2016cited by this paper
• Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities

  2016cited by this paper
• Metabolic Reprogramming and Dependencies Associated with Epithelial Cancer Stem Cells Independent of the Epithelial‐Mesenchymal Transition Program

  2016cited by this paper
• Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma.

  2016cited by this paper
• Quantitative proteomics and phosphoproteomics on serial tumor biopsies from a sorafenib-treated HCC patient

  2016cited by this paper
• On Predicting lung cancer subtypes using ‘omic’ data from tumor and tumor-adjacent histologically-normal tissue

  2016cited by this paper
• Understanding the cancer cell phenotype beyond the limitations of current omics analyses

  2016cited by this paper
• Glutamine activates STAT3 to control cancer cell proliferation independently of glutamine metabolism

  2016cited by this paper
• MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells.

  2015cited by this paper
• Energy metabolism disorders in rare and common diseases. Toward bioenergetic modulation therapy and the training of a new generation of European scientists.

  2015cited by this paper
• Emerging concepts in bioenergetics and cancer research: metabolic flexibility, coupling, symbiosis, switch, oxidative tumors, metabolic remodeling, signaling and bioenergetic therapy.

  2015cited by this paper
• Targeting mitochondrial complex I using BAY 87-2243 reduces melanoma tumor growth

  2015cited by this paper
• Fatty acid carbon is essential for dNTP synthesis in endothelial cells

  2015cited by this paper
• Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non–Small Cell Lung Cancer

  2015cited by this paper
• Pyruvate carboxylase is critical for non-small-cell lung cancer proliferation.

  2015cited by this paper
• Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA.

  2015cited by this paper
• Inhibition of glutaminase selectively suppresses the growth of primary acute myeloid leukemia cells with IDH mutations.

  2014cited by this paper
• Tumor Intrinsic Subtype Is Reflected in Cancer-Adjacent Tissue

  2014cited by this paper
• Proteogenomic characterization of human colon and rectal cancer

  2014cited by this paper
• Modeling lung cancer evolution and preclinical response by orthotopic mouse allografts.

  2014cited by this paper
• Circulating Biomarkers of One-Carbon Metabolism in Relation to Renal Cell Carcinoma Incidence and Survival

  2014cited by this paper
• Changing appetites: the adaptive advantages of fuel choice.

  2014cited by this paper
• Anaplerotic Metabolism of Alloreactive T Cells Provides a Metabolic Approach To Treat Graft-Versus-Host Disease

  2014cited by this paper
• Integrated Omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact

  2014cited by this paper
• A mitochondrial switch promotes tumor metastasis.

  2014cited by this paper
• Caveolin-1-LRP6 signaling module stimulates aerobic glycolysis in prostate cancer.

  2013cited by this paper
• PGC1α expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress.

  2013cited by this paper
• Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer.

  2013cited by this paper
• Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells.

  2013cited by this paper
• Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism.

  2012cited by this paper
• Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo.

  2012cited by this paper
• The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type.

  2012cited by this paper
• Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma.

  2012cited by this paper
• Analysis of glutamine dependency in non-small cell lung cancer

  2012cited by this paper
• Pyruvate carboxylase is required for glutamine-independent growth of tumor cells

  2011cited by this paper
• 13C-pyruvate imaging reveals alterations in glycolysis that precede c-Myc-induced tumor formation and regression.

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011influential reference
• Reductive carboxylation supports growth in tumor cells with defective mitochondria

  2011cited by this paper
• Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

  2010cited by this paper
• Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity

  2010cited by this paper
• Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression

  2010cited by this paper
• IDH1 and IDH2 mutations in gliomas.

  2009cited by this paper
• Altered regulation of metabolic pathways in human lung cancer discerned by 13C stable isotope-resolved metabolomics (SIRM)

  2009cited by this paper
• The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma

  2009cited by this paper
• IDH1 and IDH2 mutations in gliomas.

  2009cited by this paper
• IDH1 and IDH2 mutations in gliomas.

  2009cited by this paper
• Molecular Cancer Antineoplastic Effect of Iodine in Mammary Cancer: Participation of 6-iodolactone (6-il) and Peroxisome Proliferator-activated Receptors (ppar)

  2009cited by this paper
• Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling.

  2009cited by this paper
• ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis

  2008cited by this paper
• Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice.

  2008cited by this paper
• Functional dynamic compartmentalization of respiratory chain intermediate substrates: implications for the control of energy production and mitochondrial diseases.

  2008cited by this paper
• Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production

  2007cited by this paper
• Mitochondrial threshold effects.

  2003cited by this paper
• The bioenergetic signature of cancer: a marker of tumor progression.

  2002cited by this paper
• Metabolic control analysis in drug discovery and disease

  2002cited by this paper
• Cellular senescence: mitotic clock or culture shock?

  2000cited by this paper
• Cellular senescence: mitotic clock or culture shock?

  2000cited by this paper
• Tissue variation in the control of oxidative phosphorylation: implication for mitochondrial diseases.

  2000cited by this paper
• Threshold Effect and Tissue Specificity

  1999cited by this paper
• THE METABOLISM OF TUMORS

  1931cited by this paper

• Unlocking metabolic flexibility in heart failure with preserved ejection fraction: Bridging fundamental mechanisms to clinical innovation

  2025cites this paper
• Feline Calicivirus Infection Manipulates Central Carbon Metabolism

  2025cites this paper
• Discovery of Di(het)arylmethane and Dibenzoxanthene Derivatives as Potential Anticancer Agents

  2024cites this paper
• Rare diseases and pyruvate kinase M2: a promising therapeutic connection.

  2024cites this paper
• USP22 supports the aggressive behavior of basal-like breast cancer by stimulating cellular respiration

  2024cites this paper
• Exploring oncology treatment strategies with tyrosine kinase inhibitors through advanced 3D models (Review)

  2024cites this paper
• Time to Change: A Systems Pharmacology Approach to Disentangle Mechanisms of Drug-Induced Mitochondrial Toxicity

  2023cites this paper
• Identifying targetable metabolic dependencies across colorectal cancer progression

  2023cites this paper
• Application of 3D Bioprinting in Liver Diseases

  2023cites this paper
• Monoterpenoids: An upcoming class of therapeutic agents for modulating cancer metastasis

  2023cites this paper
• Studies of the Antitumor Activity of Iodacetate in the Liposomal Form

  2022cites this paper
• Genetically Encoded ATP Biosensors for Direct Monitoring of Cellular ATP Dynamics

  2022cites this paper
• Pyruvate Dehydrogenase Kinase Inhibition by Dichloroacetate in Melanoma Cells Unveils Metabolic Vulnerabilities

  2022cites this paper
• Identification and validation of a two-gene metabolic signature for survival prediction in patients with kidney renal clear cell carcinoma

  2021cites this paper
• Identification of glycolysis related pathways in pancreatic adenocarcinoma and liver hepatocellular carcinoma based on TCGA and GEO datasets

  2021cites this paper
• 3D in vitro cancer models for drug screening: A study of glucose metabolism and drug response in 2D and 3D culture models

  2021cites this paper
• Metabolic therapy and bioenergetic analysis: The missing piece of the puzzle

  2021cites this paper
• Lung Tumor Growth Promotion by Tobacco-Specific Nitrosamines Involves the β2-Adrenergic Receptors-Dependent Stimulation of Mitochondrial REDOX Signaling

  2021cites this paper
• Life after Cell Death—Survival and Survivorship Following Chemotherapy

  2021cites this paper
• Involvement of cancer-derived EMT cells in the accumulation of 18F-fluorodeoxyglucose in the hypoxic cancer microenvironment

  2021cites this paper
• SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN ACUTE MYELOID LEUKEMIA.

  2021cites this paper
• Metabolomic Study on the Therapeutic Effect of the Jianpi Yangzheng Xiaozheng Decoction on Gastric Cancer Treated with Chemotherapy Based on GC-TOFMS Analysis

  2021cites this paper
• Differences in the Central Energy Metabolism of Cancer Cells between Conventional 2D and Novel 3D Culture Systems

  2021cites this paper
• Selenium detoxification is required for cancer cell survival

  2020cites this paper
• Unlocking the potential of HK2 in cancer metabolism and therapeutics.

  2020cites this paper
• Competitive glucose metabolism as a target to boost bladder cancer immunotherapy

  2020cites this paper
• Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity

  2020cites this paper
• Caffeine and Cisplatin Effectively Targets the Metabolism of a Triple-Negative Breast Cancer Cell Line Assessed via Phasor-FLIM

  2020cites this paper
• Targeting Human Lung Adenocarcinoma with a Suppressor of Mitochondrial Superoxide Production

  2020influential citation
• Chemopreventive Potential of Flavones, Flavonols, and their Glycosides

  2020cites this paper
• S-Palmitoylation as a Functional Regulator of Proteins Associated with Cisplatin Resistance in Bladder Cancer

  2020cites this paper
• Inhibition of pyruvate dehydrogenase kinase-1 by dicoumarol enhances the sensitivity of hepatocellular carcinoma cells to oxaliplatin via metabolic reprogramming

  2020cites this paper
• Total Cellular ATP Production Changes With Primary Substrate in MCF7 Breast Cancer Cells

  2020cites this paper
• Lactate in the Tumor Microenvironment: An Essential Molecule in Cancer Progression and Treatment

  2020cites this paper
• Hypoxia-mediated drug resistance in breast cancers.

  2020cites this paper
• Click-Nucleic-Acid-Containing Codelivery System Inducing Collapse of Cellular Homeostasis for Tumor Therapy through Bidirectional Regulation of Autophagy and Glycolysis.

  2020cites this paper
• Drug development

  2020cites this paper
• Identi cation and validation of a two‐gene metabolic signature for survival prediction in patients with kidney renal clear cell carcinoma

  2020cites this paper
• Selenium detoxification is required for cancer-cell survival

  2020cites this paper
• Interweaving Tumor Heterogeneity into the Cancer Epigenetic/Metabolic Axis

  2019cites this paper
• Recent Progress in Lab-On-a-Chip Systems for the Monitoring of Metabolites for Mammalian and Microbial Cell Research

  2019cites this paper
• Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches

  2019cites this paper
• Resveratrol slows cell growth by targeting the Warburg effect and stimulating mitochondria metabolism

  2019cites this paper
• Evaluating the Role of RARβ Signaling on Cellular Metabolism in Melanoma Using the Seahorse XF Analyzer.

  2019cites this paper
• Non-proteolytic ubiquitination of Hexokinase 2 by HectH9 controls tumor metabolism and cancer stem cell expansion

  2019cites this paper
• Live cell imaging of signaling and metabolic activities.

  2019cites this paper
• The Whys and Hows of Calculating Total Cellular ATP Production Rate.

  2019cites this paper
• NKX2-8 deletion-induced reprogramming of fatty acid metabolism confers chemoresistance in epithelial ovarian cancer

  2019cites this paper
• Metabolic reprogramming of cancer by chemicals that target glutaminase isoenzymes.

  2019cites this paper
• Metabolomics: a systems approach in studying of cancer biology

  2019cites this paper
• Why the tumor cell metabolism is not that abnormal

  2019cites this paper
• Prognostic implications of markers of the metabolic phenotype in human cutaneous melanoma

  2019cites this paper
• Alternol eliminates excessive ATP production by disturbing Krebs cycle in prostate cancer

  2019cites this paper
• Glucose-derived acetate and ACSS2 as key players in cisplatin resistance in bladder cancer.

  2019cites this paper
• Identification and Verification of the Main Differentially Expressed Proteins in Gastric Cancer via iTRAQ Combined with Liquid Chromatography-Mass Spectrometry

  2019cites this paper
• Redox mechanism of levobupivacaine cytostatic effect on human prostate cancer cells

  2018cites this paper
• Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease

  2018cites this paper
• A Novel Multiple-Read Screen for Metabolically Active Compounds Based on a Genetically Encoded FRET Sensor for ATP

  2018cites this paper
• Glycolysis Inhibitors Monoiodoacetate and 2-Deoxyglucose as Antitumor Agents: Experimental Study on Lewis Lung Carcinoma Model

  2018cites this paper
• Anti-cancer effect of a novel 2,3-didithiocarbamate-substituted naphthoquinone as a tumor metabolic suppressor in vitro and in vivo.

  2018cites this paper
• Resveratrol integrates metabolic and growth effects in PC3 prostate cancer cells-involvement of prolyl hydroxylase and hypoxia inducible factor-1.

  2018cites this paper
• Looking to the metabolic landscapes for prostate health monitoring

  2017cites this paper
• Mitochondria in cancer.

  2017cites this paper
• Teaching the basics of reactive oxygen species and their relevance to cancer biology: Mitochondrial reactive oxygen species detection, redox signaling, and targeted therapies

  2017cites this paper
• In vivo Studies for Drug Development via Oral Delivery: Challenges,Animal Models and Techniques

  2017cites this paper